Pulmonary Rehabilitation and Exercise Training in Chronic Obstructive Pulmonary Disease

Rainer Gloeckl, Tessa Schneeberger, Inga Jarosch, Klaus Kenn, Rainer Gloeckl, Tessa Schneeberger, Inga Jarosch, Klaus Kenn

Abstract

Background: Chronic obstructive pulmonary disease (COPD) is a common condition that is becoming increasingly prevalent. It affects 13.2% of the population over age 40 in Germany. In 2020, it will be the third most common cause of morbidity and mortality around the world. It markedly impairs the quality of life of those who suffer from it and presents a major economic challenge to the health-care system.

Methods: This review is based on pertinent publications retrieved by a selective literature search and on the authors' clinical experience.

Results: Pulmonary rehabilitation (PR) for patients with COPD is supported by evidence on the highest level. It is associated with statistically significant (p <0.001) and clinically relevant improvement in physical performance (6-minute walk distance: + 44 m; 95% confidence interval [33; 55]), shortness of breath (Chronic Respiratory Disease Questionnaire: +0.79 points [0.56; 1.03]), and the quality of life (Saint George´s Respiratory Questionnaire: -6.9 points [-9.3; -4.5]). The benefits of PR are especially evident after an acute exacerbation of COPD: it significantly lowers the rate of readmission to the hospital (odds ratio 0.22 [0.08; 0.58], p = 0.002) and improves physical performance ability (6-minute walk distance: + 62 m [38; 86] and the quality of life (Saint George´s Respiratory Questionnaire: -7.8 points [-12.1; -3.5]; p <0.001 for both).

Conclusion: PR is an effective and cost-effective therapeutic intervention that improves physical performance ability, shortness of breath, and the quality of life in patients with COPD, but it has not yet been fully implemented as recommended in the relevant guidelines. There is a need for targeted, problem-oriented referral to a range of PR programs with problem-specific content. The necessary outpatient PR structures still need to be established in Germany.

Figures

Figure 1
Figure 1
Components of a complex, multimodal rehabilitation program in COPD (chronic obstructive pulmonary disease)
Figure 2
Figure 2
Relevance of an active lifestyle in chronic obstructive pulmonary disease (COPD)—data adjusted for age and sex. (from: Waschki B, et al.: Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 2011; 140: 331–42. [13]; reproduced with permission from Elsevier)
Figure 3
Figure 3
Rates of objectively measured comorbidities in chronic obstructive pulmonary disease (COPD) (after Vanfleteren et al. [e1])

References

    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) Report. Global strategy of the diagnosis, management, and prevention of chronic obstructive pulmonary disease. (last accessed on 15 January 2018) 2017
    1. Rochester CL, Vogiatzis I, Holland AE, et al. An Official American Thoracic Society/European Respiratory Society Policy Statement: Enhancing implementation, use, and delivery of pulmonary rehabilitation. Am J Respir Crit Care Med. 2015;192:1373–1386.
    1. Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188:e13–e64.
    1. Ries AL, Bauldoff GS, Carlin BW, et al. Pulmonary rehabilitation: joint ACCP/AACVPR evidence-based clinical practice guidelines. Chest. 2007;131:4S–42S.
    1. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2 CD003793.
    1. Kenn K, Gloeckl R, Soennichsen A, et al. Predictors of success for pulmonary rehabilitation in patients awaiting lung transplantation. Transplantation. 2015;99:1072–1077.
    1. Puhan MA, Gimeno-Santos E, Scharplatz M, Troosters T, Walters EH, Steurer J. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2011 CD005305.
    1. Gillissen A, Haidl P, Kohlhäufl M, Kroegel K, Voshaar T, Gessner C. The pharmacological treatment of chronic obstructive pulmonary disease. Dtsch Arztebl Int. 2016;113:311–316.
    1. Puhan MA, Gimeno-Santos E, Cates CJ, Troosters T. Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2016;12 CD005305.
    1. Puhan MA. Managing an acute exacerbation of COPD: is pulmonary rehabilitation the solution? Abstract. Denver, Colorado (USA) Annual Meeting of the American Thoracic Society. 2015
    1. Magnussen H, Kirsten AM, Kohler D, Morr H, Sitter H, Worth H. Guidelines for long-term oxygen therapy German Society for Pneumology and Respiratory Medicine. Pneumologie. 2008;62:748–756.
    1. Koehnlein T, Schonheit-Kenn U, Winterkamp S, Welte T, Kenn K. Noninvasive ventilation in pulmonary rehabilitation of COPD patients. Respir Med. 2009;103:1329–1336.
    1. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest. 2011;140:331–342.
    1. Gloeckl R, Halle M, Kenn K. Interval versus continuous training in lung transplant candidates: arandomized trial. J Heart Lung Transplant. 2012;31:934–941.
    1. Gloeckl R, Marinov B, Pitta F. Practical recommendations for exercise training in patients with COPD. Eur Respir Rev. 2013;22:178–186.
    1. Liao WH, Chen JW, Chen X, et al. Impact of resistance training in subjects with COPD: a systematic review and meta-analysis. Respir Care. 2015;60:1130–1145.
    1. Fisher J, Steele J, Bruce-Low S, Smith D. Evidence-based resistance training recommendations. Medicina Sportiva. 2011;15:147–162.
    1. Gosselink R, De Vos J, van den Heuvel SP, Segers J, Decramer M, Kwakkel G. Impact of inspiratory muscle training in patients with COPD: what is the evidence? Eur Respir J. 2011;37:416–425.
    1. Chen RC, Li XY, Guan LL, et al. Effectiveness of neuromuscular electrical stimulation for the rehabilitation of moderate-to-severe COPD: a meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:2965–2975.
    1. Gloeckl R, Jarosch I, Bengsch U, et al. What‘s the secret behind the benefits of whole-body vibration training in patients with COPD? A randomized, controlled trial. Respir Med. 2017;126:17–24.
    1. Gloeckl R, Heinzelmann I, Baeuerle S, et al. Effects of whole body vibration in patients with chronic obstructive pulmonary disease–a randomized controlled trial. Respir Med. 2012;106:75–83.
    1. Dhein Y, Munks-Lederer C, Worth H. Evaluation eines ambulanten strukturierten Schulungsprogramms fur Patienten mit COPD - eine Pilotstudie. Pneumologie. 2003;57:591–597.
    1. Paone G, Serpilli M, Girardi E, et al. The combination of a smoking cessation programme with rehabilitation increases stop-smoking rate. J Rehabil Med. 2008;40:672–677.
    1. van Helvoort HA, Willems LM, Dekhuijzen PR, van Hees HW, Heijdra YF. Respiratory constraints during activities in daily life and the impact on health status in patients with early-stage COPD: a cross-sectional study. NPJ Prim Care Respir Med. 2016;26
    1. Bott J, Blumenthal S, Buxton M, et al. Guidelines for the physiotherapy management of the adult, medical, spontaneously breathing patient. Thorax. 2009;64(1):i1–i51.
    1. Janssen DJ, Spruit MA, Leue C, et al. Symptoms of anxiety and depression in COPD patients entering pulmonary rehabilitation. Chron Respir Dis. 2010;7:147–157.
    1. Lacasse Y, Rousseau L, Maltais F. Prevalence of depressive symptoms and depression in patients with severe oxygen-dependent chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2001;21:80–86.
    1. Keil DC, Stenzel NM, Kuhl K, et al. The impact of chronic obstructive pulmonary disease-related fears on disease-specific disability. Chron Respir Dis. 2014;11:31–40.
    1. Tselebis A, Bratis D, Pachi A, et al. A pulmonary rehabilitation program reduces levels of anxiety and depression in COPD patients. Multidiscip Respir Med. 2013;8
    1. Harrison SL, Greening NJ, Williams JE, Morgan MD, Steiner MC, Singh SJ. Have we underestimated the efficacy of pulmonary rehabilitation in improving mood? Respir Med. 2012;106:838–844.
    1. Schols AM, Broekhuizen R, Weling-Scheepers CA, Wouters EF. Body composition and mortality in chronic obstructive pulmonary disease. Am J Clin Nutr. 2005;82:53–59.
    1. Ferreira IM, Brooks D, White J, Goldstein R. Nutritional supplementation for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2012 12CD000998.
    1. Abholz H, Gillissen A, Magnussen H, et al. Nationale Versorgungsleitlinie COPD Version 19. last accessed on 3 May 2017
    1. Cindy Ng LW, Mackney J, Jenkins S, Hill K. Does exercise training change physical activity in people with COPD? A systematic review and meta-analysis. Chron Respir Dis. 2012;9:17–26.
    1. Lahham A, McDonald CF, Holland AE. Exercise training alone or with the addition of activity counseling improves physical activity levels in COPD: a systematic review and meta-analysis of randomized controlled trials. Int J Chron Obstruct Pulmon Dis. 2016;11:3121–3136.
    1. Breyer MK, Breyer-Kohansal R, Funk GC, et al. Nordic walking improves daily physical activities in COPD: a randomised controlled trial. Respir Res. 2010;11
    1. Glöckl R, Göhl O, Spielmanns M, et al. Stellenwert ambulanter, gerätegestützter Trainingstherapie bei Atemwegs- und Lungenkrankheiten. Pneumologie. 2016;70:446–453.
    1. Jany B. Klug entscheiden in der Pneumologie. Dtsch Arztebl. 2016;113 A-930.
    1. Korczak D, Huber B, Steinhauser G, Dietl M. Health Technology Assessment. Köln: 2010. Versorgungssituation und Wirksamkeit der ambulanten im Vergleich mit der stationären pneumologischen Rehabilitation DIMDI Schriftenreihe.
    1. Spruit MA, Augustin IM, Vanfleteren LE, et al. Differential response to pulmonary rehabilitation in COPD: multidimensional profiling. Eur Respir J. 2015;46:1625–1635.
    1. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;1877:28–35.

Source: PubMed

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe

3
Subskrybuj